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Abstract Contrast-enhanced CT coronary angiography
(CTCA) has evolved as a reliable alternative imaging
modality technique and may be the preferred initial diagnostic
test in patients with stable angina with intermediate pre-test
probability of CAD. However, because CTCA is moderately
predictive for indicating the functional significance of a
lesion, the combination of anatomic and functional imaging
will become increasingly important. The technology will
continue to improve with better spatial and temporal
resolution at low radiation exposure, and CTCA may
eventually replace invasive coronary angiography. The
establishment of the precise role of CTCA in the diagnosis
and management of patients with stable angina requires high-
quality randomised study designs with clinical outcomes as a
primary outcome.
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Introduction
Stable angina is a common and disabling disease, and
occurs when there is regional myocardial ischaemia caused
by inadequate coronary perfusion due to chronic coronary
obstruction. Despite the fact that William Heberden gave a
clear description of stable angina as early as 1768, the
optimal strategy for diagnosis in stable angina is still
evolving and a variety of non-invasive and invasive tests
are available.
Traditionally, ischaemic testing includes exercise ECG
and stress myocardial perfusion imaging techniques for the
non-invasive identification of inducible ischaemia, but non-
invasive anatomic testing is emerging. Invasive coronary
angiography (ICA) is generally considered the standard of
reference for the detection of significant coronary artery
stenosis.
Multi-slice CT (MSCT) has rapidly evolved as an
alternative imaging test because of its non-invasive nature
and high diagnostic performance. Cardiac CT has two
modes: a) non-contrast enhanced CT to detect and quantify
coronary calcium and b) contrast-enhanced CT to detect
non-obstructive and obstructive coronary atherosclerosis.
Coronary calcium is considered a proven marker of the
presence of atherosclerosis and the prognostic value of
coronary calcium scoring is independent and incremental to
the predictive value of traditional risk factors [1].
Remarkable advances in MSCT technology have been
achieved with successive CT scanner generations. The current
state-of-the-art 64 slice CT scanners, necessary for contrast-
enhanced CT coronary angiography (CTCA), provide high-
definition images of coronary non-obstructive and obstructive
atherosclerosis, with characterisation of coronary plaques into
calcific and non-calcific components [2–4].
Despite the growing use of MSCT, its clinical utility in
the hierarchy of coronary investigations remains to be
established. There is an ongoing debate whether manage-
ment of patients with stable angina should be primarily
based on anatomical or functional testing. Notably, there is
a well-known dissociation between the functional relevance
of a coronary obstruction (ischaemia) and the severity of a
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coronary obstruction that is haemodynamically significant
[5, 6]. This report provides a current perspective on the
potential role of MSCT in patients presenting with stable
angina. We propose an alternative diagnostic testing algorithm
usingMSCT for the management of stable angina, and discuss
limitations and future directions of CTCA.
Current diagnosis and management of patients
with stable angina
The current diagnostic work-up of patients with stable
angina is based on the outcome of clinical evaluation,
assessment of ischaemia and subsequent management
taking into account prognosis and effectiveness of medical
and revascularisation therapy [7, 8].
Clinical evaluation includes age, gender, history of chest
pain, weight, blood pressure, ECG and laboratory tests of
glucose and total cholesterol.
History of chest pain allows classification into A) typical
angina that meets the following characteristics: 1) substernal
chest discomfort; 2) provoked by exertion or emotional stress
and 3) relieved by rest or nitroglycerine; B) Atypical angina
that meets two of the above characteristics and C) non-anginal
chest pain that meets only one or none of these characteristics.
The clinical evaluation is derived from simple easily
obtainable variables and is used as the initial step in the
diagnosis and management of patients with stable angina to
categorise these patients into a low, intermediate or high
pre-test probability group.
The pre-test probability categorisation is important
because 1) it has a significant impact on the post-test
probability of disease; 2) the prognosis and management of
patients is different in each category; 3) the selection of a
diagnostic test depends on the consequences this may have
on the two above considerations.
Based on the above considerations and in agreement
with the guidelines, a diagnostic algorithm that is currently
often used is presented (Fig. 1). This algorithm is an
oversimplification of the sometimes complex clinical
situation of patients presenting with stable angina and
follows three steps: 1) pre-test risk assessment; 2) selection
of a diagnostic test; and 3) subsequent patient management.
The pre-test probability of the presence of obstructive
CAD can be estimated using prediction score algorithms
devised by Diamond and Forrester or the Duke Clinical
Symptomatic 
Age, gender, chest pain type, risk factors *
1. Lifestyle  changes
- Stop smoking
- Reduce weight
- Start excercising
1. Lifestyle changes
2. Intense risk modification
- Lower blood pressure
- Lower cholesterol
- Lower glucose
Intermediate            
pre-test probability          
(10-90%)
High                     
pre-test probability          
(>90%)
Low                    
pre-test probability                  
(5-10%)
Excercise ECG           
for ischaemic 
testing           
Ischaemic Testing 
for ICA
Ischaemic testing for 
revascularisation 
PRE-TEST
PROBABILITY
GATEKEEPER
TEST FOR
PATIENT
MANAGEMENT
Very low                
pre-test probability               
(<5%)
No testing  
Negative Inconclusive Positive Negative 
or   < 10%
> 10-15%
ICA
Negative Positive
1. Lifestyle changes
2. Intense risk modification
3. Optimal medical treatment
1. Lifestyle changes
2. Intense risk modification
3. Revascularisation (PCI/CABG)
Fig. 1 Established diagnostic algorithm. If risk factor diabetes or
hypertension is present, patients are categorised to high pre-test probability
category. CTCA computed tomography coronary angiography; ECG
electrocardiography; ICA invasive coronary angiography. Ischaemic
testing includes stress myocardial perfusion imaging; SPECT or single
photon emission computed tomography [relative flow], PET or positron
emission tomography [absolute flow], MRI or magnetic resonance
imaging [flow reserve]; stress echocardiography [wall motion]
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Score using the variables from the clinical evaluation [9, 10].
There is no consensus as to the exact range of pre-test
likelihood classification into low, intermediate or high
pre-test risk, and we have chosen for a very low (<5%),
low (5–10%), intermediate (10–90%), and high (>90%)
pre-test risk [11].
Cardiac diagnostic tests reveal the presence of myocar-
dial ischaemia shown as presence of electrocardiographic
ST-segment depression, myocardial perfusion defects or
induced wall motion abnormalities. The ischaemic cascade
demonstrates the sequence of abnormalities that occur
during ischaemia (Fig. 2). Perfusion abnormalities are the
earliest manifestation of coronary ischaemia that can be
detected by highly sensitive tests such as SPECT/MRI/
contrast echocardiography, followed by systolic dysfunc-
tion and associated stress-induced motion abnormalities,
then ECG abnormalities as a later manifestation of
ischaemia and finally angina [12]. The diagnostic accuracy
of the various tests is summarised in Table 1.
The post-test probability of CAD depends on the pre-test
risk and the sensitivity and specificity of the test [9, 10].
The selection of a test depends predominately on the
diagnostic accuracy of the test, but also other factors may
play a role including safety, costs, availability, patient’s
convenience and the use of radiation. No test is perfect and
the goal of a test is to provide a level of certainty indicating
the presence or absence of CAD (Fig. 3). The level of
certainty is arbitrary and depends on the estimated
prognosis of patients with a ‘missed’ diagnosis or whether
additional testing is able to further improve the level of
certainty allowing better patient decision management.
Thus, a test may serve as a gatekeeper for additional
testing, while a functional test may also be useful to make a
decision regarding medical or revascularisation treatment.
At the very low end of the likelihood spectrum no testing
is required. Patients with low pre-test probability may
undergo the inexpensive, widely available bicycle ECG
stress test. Patients with intermediate pre-test probability are
referred for functional testing to assess the presence and
extent of myocardial ischaemia to guide the decision for
medical treatment. Patients at high risk do not require
testing to confirm the presence of the high likelihood of
CAD but require testing to assess the extent of ischaemia to
guide the decision for revascularisation.
Patient management following clinical evaluation, pre-
test risk classification and outcome of selected testing is
based on the presence of modifiable (smoking, obesity,
exercise) or treatable risk factors (blood pressure, choles-
terol, glucose), on the presence of mild to moderate extent
of ischaemia requiring medical treatment or large extent of
ischaemia where revascularisation has shown to reduce the
extent of ischaemia and improve prognosis [13, 14].
Role of MSCT in diagnosis and management
of patients with stable angina
So far, non-invasive tests, assessing the presence of coronary
obstructions, were based upon the detection of myocardial
ischaemia caused by coronary flow limiting stenosis. These
tests were predominately used as ‘gatekeeper’ for invasive
coronary angiography, the anatomical counterpart of myocar-
dial perfusion abnormalities, because invasive coronary
angiography is expensive, patient-unfriendly and in a few
cases associated with complications [15].
The introduction of CTCA may cause a shift in the
current paradigm of the diagnostic work-up of patients with
stable angina, because the non-invasive nature of this
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Fig. 2 The ischaemic cascade.
Myocardial dysfunction occurs
in a predictable sequence of
events which is detectable prior
to clinical symptoms
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imaging modality may decrease the threshold to refer
patients to establish the anatomical presence of coronary
atherosclerotic obstruction and may provide three-dimensional
information that might be of value to resolve complex coronary
pathology [16] (Fig. 4). The presence of coronary calcium, as
assessed by non-contrast enhanced CT, is a marker of the
presence of coronary atherosclerosis [1], but its presence does
not necessarily imply the presence of a significant coronary
obstruction. There is a direct relation between the magnitude
of the coronary calcium score and the presence of a coronary
obstruction, which is located anywhere in the coronary tree
and not necessarily at the calcific plaque site [17, 18]. The
absence of coronary calcium does not completely exclude the
presence of coronary atherosclerosis, and in a few cases
non-calcified plaques are present, although these are
mostly nonobstructive [19]. The absence of coronary
calcium is associated with a very low risk of adverse
coronary events [20].
Coronary calcium scoring may be useful as an initial,
reliable gatekeeper for ischaemic testing in patients with
a very low and low pre-test probability of CAD (Fig. 4).
The use of the coronary calcium score is acceptable
because it is patient-friendly, inexpensive and contrast is
not necessary, but it is associated with, albeit, low
radiation exposure (< 1 mSv).
The presence of extensive coronary calcium seriously
limits the reliability of CTCA and consequently in patients
with a high coronary calcium score (Agatston >400) an
ischaemic test would be more effective than a CTCA (Fig. 4).
The presence of obstructive coronary atherosclerosis is
assessed by contrast-enhanced CTCA. The diagnostic
performance of CTCA has been extensively investigated
in patients with intermediate and high pre-test probability
by comparing the diagnostic accuracy of 64-slice CTCA to
the gold standard invasive coronary angiography (Tables 2
and 3). The very high negative predictive value outperforms
any other test and strongly supports the use of CTCA as
reliable gatekeeper to invasive coronary angiography, in
particular, in patients at intermediate risk [21].
An alternative approach to the established diagnostic
algorithm in patients with low to intermediate pre-test risk
is the use of coronary CTCA as the initial test (Fig. 4). A
negative CTCA is highly reliable to exclude disease and is
associated with an excellent short to intermediate prognosis
[22–25]. The positive predictive value of CTCA to detect a
significant coronary obstruction is only moderate and it is
recommended to perform an ischaemia test in patients who,
according to CTCA, have left main and/or three-vessel
disease, which is associated with an adverse prognosis that
may be improved by revascularisation [26]. In patients with
Sensitivity (%) Specificity (%)
Exercise ECG 65–70 70–75
Exercise stress echocardiography 80–85 80–85
Dobutamine stress echo 80–85 85–90
Exercise myocardial perfusion SPECT 85–90 85–90
Pharmacological myocardial perfusion SPECT 80–90 80–90
Table 1 The diagnostic
performance of non-invasive
cardiac tests for the diagnosis of
CAD [12]
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Fig. 3 Relation between pre- and
post-test probability. Diagnostic
accuracy improves with a test
with a higher sensitivity and
specificity. Bayesian theory has
shown that the value of non-
invasive testing is greatest in
patients with an intermediate pre-
test probability of having CAD.
Assume certainty level. Very low
pre-test probability (<5%): uncer-
tainty will not be achieved. Low
pre-test probability (5–10%): only
certainty with a negative test
result. Intermediate pre-test
probability: (10–90%): certainty
with a negative and positive test
result. High pre-test probability:
(>90%): only certainty with a
positive test result
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a high pre-test probability the question is one of prognosis
and benefit from revascularisation rather than diagnosis and
an initial functional test should assess the presence and
extent of ischaemia to guide to medical treatment or referral
to invasive coronary angiography and revascularisation.
Limitations of CTCA
The limitations of CTCA, despite remarkable technical
developments, are fivefold: 1) calcification blooming
artefacts; 2) limited spatial and temporal resolution; 3)
unpredictability of haemodynamic significance of interme-
diate coronary lesions; 4) radiation exposure; and 5)
difficulties to acquire motion-free, high-quality images in
patients with arrhythmias.
Coronary calcifications cause blooming artefacts of coro-
nary calcific lesions which either obscure adequate evaluation
of the underlying coronary lumen or induce an overestimation
of the severity of a coronary obstruction. Both problems result
in limitations in the diagnostic performance of CTCA and
even the introduction of newly developed CT technology with
improved spatial resolution or use of dual-energy CT may not
fully reduce this problem.
Symptomatic 
Age, gender, chest pain type, risk factors *
Intermediate             
pre- test probability 
(10-90%)
High                      
pre-test probability              
(>90%)
Low                          
pre-test probability                  
(5-10%)
CCS  for CTCA or 
ischaemic testing           
CTCA                         
for ischaemic 
testing
Ischaemic testing           
for revascularizaton 
PRE-TEST
PROBABILITY
GATEKEEPER
TEST FOR
PATIENT
MANAGEMENT
Ischaemic
testing
Very low                   
pre-test probability                
(<5%)
Negative RCA,  Cx
RCA/Cx
Negative 
or < 10%
>10%
LM, LAD
3-VD
Negative 
(0) 
Interm.
(0-400) 
High 
(>400) 
Negative 
or < 10%
>10%
ICA
Negative Positive
1. Lifestyle  changes
- Stop smoking
- Reduce weight
- Start excercising
1. Lifestyle changes
2. Intense risk modification
- Lower blood pressure
- Lower cholesterol
- Lower glucose
1. Lifestyle changes
2. Intense risk modification
3. Optimal Medical Treatment
1. Lifestyle changes
2. Intense risk modification
3. Revascularisation      
- PCI/CABG 
Fig. 4 Alternative diagnostic algorithm. * If risk factor diabetes or
hypertension is present, patients are categorised to high pre-test
probability category. CCS: coronary calcium score (expressed as
Agatston Score), CTCA: computed tomography coronary angiogra-
phy, ICA: invasive coronary angiography, RCA: right coronary artery,
Cx: left circumflex artery, LM: left main, LAD: left anterior
descending artery, 3-VD: three-vessel disease. Ischaemic testing
includes stress myocardial perfusion imaging: SPECT or single photon
emission computed tomography [relative flow], PET or positron
emission tomography [absolute flow], MRI or magnetic resonance
imaging [flow reserve]; stress echocardiography [wall motion]
Table 2 Diagnostic performance of 64-slice CTCA and dual-source CTCA for the detection of significant CAD on a per-patient basis
Scanner type Sensitivity (range, %) Specificity (range, %) PPV (range, %) NPV (range, %)
Meta-analyses / systematic review ♦ 64 93–99 88–98 93 96–100
Multi-centre trials ◘ 64 85–99 64–90 64–91 83–99
Single-centre trials □ DS 92–100 73–98 68–96 92–100
♦ Vanhoenacker [46]; Abdulla [47]; Stein [27]; Mowatt [48]
◘ Meijboom [44]; Miller [45]; Budoff [43]
□ Scheffel [49]; Leber [50]; Weustink [51]; Johnson [52]; Brodoefel [53]; Ropers [54]; Tsiflikas [55]; Heusschmidt [56]; Scheffel [37]; Leschka [57]
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The spatial and temporal resolution of current CT
technology falls short of the resolution obtained with
invasive coronary angiography. This becomes particularly
apparent in the diagnostic performance of smaller parts of
the coronary tree, distal segments and side branches, where
the sensitivity is approximately 79% as compared with over
90% in the proximal and mid coronary segments [27].
Motion artefacts, in particular in the RCA, are still present
due to limited temporal resolution of CTCA.
The combination of calcifications and limited resolution
results in a rather high number of false-positive outcomes,
which become predominantly apparent when the diagnostic
accuracy is calculated on a segment-based analysis (Table 3)
and therefore as of yet cannot replace invasive coronary
angiography, which requires precise anatomical delineation
of coronary obstructions prior to PCI or CABG.
New CT technology with faster and more sensitive
detectors using gemstone technology and introduction of
iterative reconstruction algorithms may further improve
spatial resolution. Dual energy CT may be helpful to more
precisely characterise plaque components [28] and temporal
resolution may be further improved by building CT
configurations with more X-ray tubes.
The unpredictability of the haemodynamic significance
of CT intermediate coronary lesions raises issues as to the
referral for coronary revascularisation (PCI or CABG)
which is deemed necessary if there is objective evidence
of moderate to severe myocardial ischaemia [29, 30].
Therefore, it is recommended to perform a myocardial
perfusion challenge following a CT scan with an interme-
diate lesion. Hybrid imaging with PET-CT and SPECT-CT
integrating both functional and anatomic information has,
in a few preliminary studies, shown that this yields a better
diagnostic performance than stand-alone CT, SPECT or
PET [31–34].
The radiation exposure, and the associated increased
lifetime risk of cancer and mortality, in particular in
younger individuals and women, is of concern [35, 36].
Increased awareness among radiologists, cardiologists and
technicians should reduce the radiation exposure by using
the newest CT technology which allows tailored CT
protocols with use of prospective CT scanning [37, 38].
Unnecessary CT scanning must be avoided [39]. Institution
of these measures has significantly reduced the effective
dose to less than 4 mSv and with the use of the latest Flash
CT scanner to approximately 1 mSv [40].
The use of 320-row CT scanner, allowing whole-heart
imaging in one heart beat, may resolve arrhythmia issues,
and result in motion-free coronary imaging [41, 42].
Future
The role of CTCA in the diagnosis and management of
patients with stable angina is not firmly established. So far,
numerous studies have evaluated the diagnostic performance
of CTCA compared with invasive coronary angiography. The
majority were single-centre studies performed by experienced
investigators which probably resulted in better outcomes than
may be expected from less experienced centres, which was
already apparent in the lesser outcomes of the published three
multi-centre studies [43–45].
In addition, CTCA studies were performed in selected
patients referred for invasive coronary angiography thereby
introducing a referral bias. The spectrum of patients with
stable chest pain is much broader and also includes patients
in whom invasive coronary angiography is not deemed
necessary, but in whom CTCA as a non-invasive, patient-
friendly imaging modality may play a diagnostic role.
Investigating only patients with a positive CT scan for
invasive coronary angiography, while not investigating
patients with a negative CT scan in whom referral to invasive
coronary angiography is deemed unethical, introduces a
verification bias.
These dilemmas can be resolved by not using invasive
coronary angiography as a surrogate comparison but
instead a randomised trial of a strategy with CTCA and
CT-derived clinical management decisions compared with a
standard of care strategy with functional testing and its
derived clinical management decisions using clinical
endpoints as primary outcome and cost-effectiveness as
secondary endpoints.
These randomised studies should provide adequate
evidence, according to general accepted rigorous criteria,
Table 3 Diagnostic performance of 64-slice CTCA and dual source CTCA for the detection of significant CAD on a per-segment basis
Scanner type Sensitivity (range, %) Specificity (range, %) PPV (range, %) NPV (range, %)
Meta-analyses / systematic review ♦ 64 86–93 96–97 73–83 97–99
Multi-centre trials ◘ 64 88–90 90–97 47–76 99–99
Single-centre trials □ DS 88–97 87–98 61–89 98–99
♦ Vanhoenacker [46]; Abdulla [47]; Stein [27]; Mowatt [48]
◘ Meijboom [44]; Budoff [43]
□ Scheffel [49]; Leber [50]; Weustink [51]; Johnson [52]; Brodoefel [53]; Ropers [54]; Tsiflikas [55]; Heusschmidt [56]; Scheffel [37]; Leschka [57]
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that CTCA as an alternative to existing functional tests may
offer better patient outcome and/or may be cost-effective.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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